The years since the first sequencing of the human genome in 2003 have seen remarkable advances in knowledge of ourselves, our societies and the diseases that afflict us. However, much remains to be done in the identification of the genes responsible. This special issue includes some approaches to these enduring problems from researchers who are tackling some of the opportunities and problems generated.
The article "A RaDiCAL gene hunt" by Mihaela Pupavac, M.Sc., Ma'n H. Zawati, LL.M. and David S. Rosenblatt, M.D. "proposes a method to identify genes responsible for genetic diseases. There are an estimated 2000 genetic diseases that are caused by single gene mutations in the human genome and that segregate in a Mendelian fashion. The concept described relies upon genome sequencing of a few members, perhaps as few as 3, members of consanguineous families and is showing a wide application.
The problems that are posed to relate alterations in DNA sequence to gene function and their consequences are illustrated in several articles.
One of these articles entitled, "Prediction of deleterious single nucleotide polymorphisms and their effect on the sequence and structure of the human CCND1 gene" by Bharath Yoganarasimha, B.E, Vivek Chandramohan, M.Sc,Thirupathihalli Pandurangappa, Krishna Murthy, M.Tech, Bhavya Somalapura Gangadharappa, M.Tech, Gowrishankar Bychapur Siddaiah, Ph.D and Makari Hanumanthappa, M.Sc., illustrates that even with extensive knowledge of DNA primary sequences the explanation of a phenotype can remain elusive.
Reinforcing this is the contribution entitled "The 9p21.3 risk locus for coronary artery disease: A 10-year search for its mechanism" by Naif Almontashiri, PhD, This article illustrates well the problems in associating risk loci identified by GWAS with a phenotype. The approach that is being used to address this problem is extensive sequencing of risk loci from stratified patient populations.
In the same vein the article "The association between interleukin 6 _174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis", by Jonny K. Fajar, MD, an Azharuddin, PhD, illustrates a similar problem of associating loci identified by GWAS with disease causing mutations. Underlying these difficulties are modifier genes and modifiers of genes that alter the penetrance of disease causing mutations. The discovery of such modifier genes to explain disease phenotypes is the objective of many intensive searches.
Added to these endeavors are the influences of DNA methylation on gene expression and the article "BRCA1 promoter methylation in peripheral blood cells and predisposition to breast cancer" by Nisreen M. Al-Moghrabi, PhD, illustrates new levels of complexity in explaining disease phenotypes. In addition the review "Epigenetics of human diseases and scope in future therapeutics " by Monis Bilal Shams, PhD; Firoz A Samad, M.Sc.; Syed N. Imam, MD, Naweed A Zaman, MD, Mohammed A. Samman, Ph.D, discusses the diseases linked with epigenetics changes and possible routes for the development of therapies.
These articles contribute to the new era of genetics that has arisen from DNA sequencing and is now benefitting from the reducing costs of sequencing, that is generating the ability to mount extensive sequencing projects. There are now many challenges for geneticists to use these data to explain disease phenotypes and to develop therapies.
The present issue of Journal of Taibah University Medical Sciences with the symposium dedicated to Genetics, in addition to other articles, will certainly enrich the goals of this journal and attract a wider readership.
